Sign Out
Gliclazide is indicated for the treatment of type II diabetes in association with dietary measures and with physical exercise when these measures alone are inadequate to control blood glucose.
During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg- 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.
